[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"bradykinesia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:bradykinesia":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":5},"100623495","prtms-as-an-intervention-for-bradykinesia-in-parkinsons-disease-100623495",false,"NCT07397377","prTMS as an Intervention for Bradykinesia in Parkinson's Disease","Enhancing rTMS Effects Through a State-Dependent Approach - An Intervention for Bradykinesia in Parkinson's Disease","ADAPT-BK","Inclusion Criteria:\n\nAbove 18 years of age. Clinically established or probable Parkinson's Disease (PD), according to the Movement Disorder Society.\n\nClinical Diagnostic Criteria for PD. Stable antiparkinsonian medicine for at least four weeks. Signed informed consent.\n\nExclusion Criteria:\n\nPsychiatric disorders. Current use of antipsychotic medication, Donepezil, or GABAergic agents (e.g., pregabalin, gabapentin).\n\nFrequent benzodiazepine or opioid use defined as more than once per week on a regular basis.\n\nHistory of neurological disease other than PD. Past or present mental illness. History of epilepsy\u002Fconditions associated with increased risk of seizure induction through transcranial magnetic stimulation (TMS).\n\nClose relatives suffering from epilepsy\u002Fconditions associated with increased risk of seizures.\n\nContraindications for magnetic resonance imaging (MRI) Contraindications for TMS Female participants of childbearing age must not be pregnant and must use contraception during the trial.\n\nRefuse to be informed about new health-related information and accidental health-related findings that might appear through participation in the study.","ALL","18 Years","80 Years",{"count":21,"type":22},27,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study investigates the use of patterned repetitive transcranial magnetic stimulation (prTMS) as an intervention for bradykinesia in Parkinson's Disease (PD). More specifically, the study aims to determine whether prTMS over the supplementary motor area (SMA) can reduce severity of bradykinesia in PD patients. This approach may open for more targeted and effective treatment of bradykinesia in PD.",[28,29],"Bradykinesia","Parkinson Disease",[28,31,32,33,34,35,36,37,38],"Basal Ganglia Diseases","Parkinson's Disease","Central Nervous System Diseases","Movement Disorders","Synucleinopathies","Neurodegenerative Diseases","SMA","TMS","RECRUITING","2026-02-04",{"date":42,"type":43},"2026-02-09","ACTUAL",{"date":45,"type":43},"2025-12-16",{"date":47,"type":22},"2027-05-01",{"name":49,"class":50},"Danish Research Centre for Magnetic Resonance","OTHER"]